Sectors
Six years after AIG bailout, trial asks: was it legal?
One of the more unusual trials to come out of the 2008 financial crisis is set to begin on Monday, when a federal judge will consider whether the U.S. government's rescue of American International Group Inc (AIG.N) was, in fact, legal.
UBS launches share-for-share exchange for new holding company
UBS said on Monday it was launching a share-for-share exchange to set up a new holding company, UBS Group AG, part of a restructuring drive to ensure it can be broken up more easily in a crisis.
Mercuria's third founder: China head eyes long game
The little known Asia head of Mercuria will be key in tying the Swiss commodity trader's $3.5 billion acquisition of JP Morgan Chase and Co's physical commodity desk into the company's China business.
Japan's Daiichi Sankyo to acquire US biopharma Ambit Biosciences
Japanese drugmaker Daiichi Sankyo Co Ltd (4568.T) has agreed to acquire U.S. biopharmaceutical company Ambit Biosciences Corp (AMBI.O) in a deal valued up to $410 million as it looks to build its presence in oncology, the companies said.